PT Kalbe Farma Tbk. (IDX:KLBF)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
885.00
+10.00 (1.14%)
Apr 28, 2026, 4:14 PM WIB
-28.63%
Market Cap 40.08T
Revenue (ttm) 35.32T
Net Income (ttm) 3.66T
Shares Out 45.29B
EPS (ttm) 80.51
PE Ratio 10.99
Forward PE 10.89
Dividend 36.00 (4.11%)
Ex-Dividend Date Jun 4, 2025
Volume 56,912,900
Average Volume 45,226,575
Open 875.00
Previous Close 875.00
Day's Range 865.00 - 885.00
52-Week Range 860.00 - 1,600.00
Beta 0.11
RSI 30.22
Earnings Date Apr 29, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as ... [Read more]

Sector Healthcare
Founded 1966
Employees 12,835
Stock Exchange Indonesia Stock Exchange
Ticker Symbol KLBF
Full Company Profile

Financial Performance

In 2025, PT Kalbe Farma Tbk.'s revenue was 35.32 trillion, an increase of 8.27% compared to the previous year's 32.63 trillion. Earnings were 3.66 trillion, an increase of 13.09%.

Financial Statements

News

There is no news available yet.